Ernesto Maddaloni

Pubblicazioni

Titolo Pubblicato in Anno
Platelet effects of anti-diabetic therapies: new perspectives in the management of patients with diabetes and cardiovascular disease FRONTIERS IN PHARMACOLOGY 2021
Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis INTERNAL AND EMERGENCY MEDICINE 2021
Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes EXPERT OPINION ON INVESTIGATIONAL DRUGS 2021
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity ENDOCRINE 2021
SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS 2021
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study JOURNAL OF DIABETES RESEARCH 2021
Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk DIABETOLOGIA 2021
Usefulness of Color Doppler Ultrasonography in the Risk Stratification of Thyroid Nodules EUROPEAN THYROID JOURNAL 2021
Correction to: "H" for Heterogeneity in the Algorithm for Type 2 Diabetes Management CURRENT DIABETES REPORT 2020
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86) THE LANCET DIABETES & ENDOCRINOLOGY 2020
Effects of covid-19 lockdown on glucose control: continuous glucose monitoring data from people with diabetes on intensive insulin therapy DIABETES CARE 2020
Adult-onset autoimmune diabetes in 2020: An update MATURITAS 2020
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) DIABETES RESEARCH AND CLINICAL PRACTICE 2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) CARDIOVASCULAR DIABETOLOGY 2020
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I) DIABETES RESEARCH AND CLINICAL PRACTICE 2020
Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics DIABETES/METABOLISM RESEARCH AND REVIEWS 2020
The vicious circle of left ventricular dysfunction and diabetes: From pathophysiology to emerging treatments THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2020
Implementing the treatment of heart failure with SGLT-2 inhibitors and sacubitril-valsartan: does money matter? EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2020
Risk factors and predictive biomarkers of early cardiovascular disease in obese youth DIABETES/METABOLISM RESEARCH AND REVIEWS 2019

Progetti di Ricerca

Gruppi di ricerca

Intervento farmacologico inibente la differenziazione delle cellule mieloidi verso un fenotipo calcificante
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine
Synergies anchoring to gravity (SynErg): a novel test to diagnose risk of falls in type 2 diabetes patients

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma